Richard Francis

SVP & Head of CMC & Quality at Synairgen Plc

Richard Francis joined in September 2021 as Head of CMC, bringing more than 35 years of experience in the development, manufacturing, regulatory approval and commercialization of many biopharmaceutical products including Cablivi®, Orthoclone OKT3®, Remicade®, and ReoPro®.

Org chart

Manager

Richard Marsden

Chief Executive Officer

Peers

Philip Monk

Chief Scientific Officer

Jody Brookes

SVP & Head of Clinical Operations

Richard Hennings

Chief Commercial Officer

Reports

Martha Byrne

VP Clinical QA

Hazel Pitt

Quality Director

Timeline

SVP & Head of CMC & Quality
September, 2021 - present

View in org chart